Literature DB >> 15811602

The protective role of DL-alpha-lipoic acid in biogenic amines catabolism triggered by Abeta amyloid vaccination in mice.

E Philip Jesudason1, J Gunasingh Masilamoni, R Kirubagaran, G Dicky John Davis, R Jayakumar.   

Abstract

The major pathological consequence of Alzheimer disease (AD) is accumulation of beta-amyloid (Abeta) peptide fibrillar plaque in the brain and subsequent inflammatory reaction associated with the surrounding cells due to the presence of these aggregates. Inflammation is the major complication associated with Abeta peptide vaccination. Abeta peptide activated T-helper cells are shown to enhance the existing-inflammatory conditions in the brain and other organs of AD patients. Hence systematic studies on potential approaches that will prevent inflammation during the vaccination are highly desired. DL-alpha-lipoic acid (LA), an antioxidant with known function as cofactor in mitochondrial dehydrogenase reactions, will be a good candidate to annul the oxidative damage due to vaccination triggered inflammation. For the first time, levels of principal neurotransmitters and their major metabolites in hippocampus and neocortex regions of brain are quantified to find out the level of inflammation. We have used high performance liquid chromatography with electro chemical detection (HPLC-EC) for monitoring neurotransmitter levels. We have shown a significant (p<0.05) reduction of 5-hydroxytryptamine (5-HT), dopamine (DA) and norepinephrine (NE) in the systemic inflammation induced (SI), vaccinated (VA) and inflammation induced vaccinated (IV) mice. Nevertheless their metabolites such as 5-hydroxyindole acetic acid (5-HIAA) and homovanillic acid (HVA) are significantly (p<0.05) increased when compared with control. Interestingly, antioxidant LA treated mice with systemic inflammation (IL), vaccinated (VL) and inflammation induced vaccinated (IVL) mice exhibited enhanced level of 5-HT, DA and NE and the concentration of 5-HIAA and HVA gradually returned to normal. These results suggest a possible new way for monitoring and modifying the inflammation and thereby preventing Abeta vaccination mediated tissue damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15811602     DOI: 10.1016/j.brainresbull.2005.01.010

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  6 in total

1.  Efficacy of DL-alpha lipoic acid against systemic inflammation-induced mice: antioxidant defense system.

Authors:  E Philip Jesudason; J Gunasingh Masilamoni; Charles E Jebaraj; Solomon F D Paul; R Jayakumar
Journal:  Mol Cell Biochem       Date:  2008-04-10       Impact factor: 3.396

2.  Inhibitory effects of short-term administration of DL-alpha-lipoic acid on oxidative vulnerability induced by Abeta amyloid fibrils (25-35) in mice.

Authors:  E Philip Jesudason; J Gunasingh Masilamoni; Ben S Ashok; B'joe Baben; V Arul; K Samuel Jesudoss; W Charles E Jebaraj; S Dhandayuthapani; S Vignesh; R Jayakumar
Journal:  Mol Cell Biochem       Date:  2008-01-26       Impact factor: 3.396

3.  Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease.

Authors:  Sandra L Siedlak; Gemma Casadesus; Kate M Webber; Miguel A Pappolla; Craig S Atwood; Mark A Smith; George Perry
Journal:  Free Radic Res       Date:  2009-02

4.  Anti-inflammatory effect of melatonin on A beta vaccination in mice.

Authors:  E Philip Jesudason; B'Joe Baben; Ben S Ashok; J Gunasingh Masilamoni; R Kirubagaran; W Charles E Jebaraj; R Jayakumar
Journal:  Mol Cell Biochem       Date:  2006-11-29       Impact factor: 3.842

5.  The Anti-Inflammatory Effects of Blueberries in an Animal Model of Post-Traumatic Stress Disorder (PTSD).

Authors:  Philip J Ebenezer; C Brad Wilson; Leslie D Wilson; Anand R Nair; Francis J
Journal:  PLoS One       Date:  2016-09-07       Impact factor: 3.240

Review 6.  Potential Therapeutic Effects of Lipoic Acid on Memory Deficits Related to Aging and Neurodegeneration.

Authors:  Patrícia Molz; Nadja Schröder
Journal:  Front Pharmacol       Date:  2017-12-12       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.